重庆凯林制药有限公司
Chongqing Carelife Pharmaceutical Co. Ltd.
Country: CN CDE+DMF+CEP VERY_HIGH
🇨🇳 CDE
41
41 products shown
🇺🇸 DMF
24
24 products shown
🇪🇺 CEP
12
12 products shown
Total
77
registrations
🇨🇳 CDE 注册 (41)
| Product | CAS | Status | Reg Number |
|---|---|---|---|
| Aripiprazole 阿立哌唑 | 129722-12-9 | Class A | Y20210000572 |
| Aripiprazole 阿立哌唑 | 129722-12-9 | Class A | Y20190001376 |
| Beraprost Sodium 贝前列素钠 | 88430-50-6 | Class A | Y20230001142 |
| Bortezomib 硼替佐米 | 179324-69-7 | Class A | Y20200000043 |
| Cabotegravir 卡替拉韦 | 1051375-10-0 | Class A | Y20240000975 |
| Cabotegravir Sodium 卡替拉韦钠 | 1051375-10-0 | Class I | Y20240001383 |
| Carfilzomib 卡非佐米 | 868540-17-4 | Class A | Y20230000329 |
| Clindamycin 克林霉素 | - | Class A | Y20190008175 |
| Clindamycin 克林霉素 | - | Class A | Y20190007868 |
| Clindamycin 克林霉素 | - | Class A | Y20190005480 |
| Cyclophosphamide 环磷酰胺 | 50-18-0 | Class I | Y20250000259 |
| Dacomitinib 达可替尼 | 1110813-31-4 | Class A | Y20230000691 |
| Dapagliflozin HS-10353 | 461432-26-8 | Class I | Y20240001191 |
| Dolutegravir Sodium 多替拉韦钠 | 1051375-16-6 | Class A | Y20240000649 |
| Entecavir 恩替卡伟 | 142217-69-4 | Class A | Y20190007159 |
| Epinastine 盐酸依匹斯汀 | 80012-43-7 | Class A | Y20190003023 |
| Ethanol 无水乙醇 | 64-17-5 | Class I | Y20250000210 |
| Etomidate 甲氧依托咪酯盐酸盐 | 33125-97-2 | Class A | Y20230000922 |
| Finerenone HS236 | 1050477-31-0 | Class I | Y20240000712 |
| Flurbiprofen 氟比洛芬酯 | 5104-49-4 | Class A | Y20170001349 |
| Granisetron 盐酸格拉司琼 | 109889-09-0 | Class A | Y20190003022 |
| Ibrutinib 伊布替尼 | 936563-96-1 | Class A | Y20230000989 |
| Iron Sucrose 蔗糖铁 | 8047-67-4 | Class A | Y20190005746 |
| Ixazomib 枸橼酸伊沙佐米 | 1239908-20-3 | Class I | Y20250000999 |
| Lenvatinib 甲磺酸仑伐替尼 | 417716-92-8 | Class A | Y20210000672 |
| Magnesium Isoglycyrrhizinate 异甘草酸镁 | 660436-69-1 | Class I | Y20250001106 |
| Methotrexate 甲氨蝶呤 | 59-05-2 | Class A | Y20230001094 |
| Mitoxantrone 盐酸米托蒽醌 | 65271-80-9 | Class A | Y20190003032 |
| Nusinersen Sodium 诺西那生钠 | - | Class I | Y20240000385 |
| Palbociclib 帕博西尼 | 571190-30-2 | Class A | Y20210001116 |
| Pemetrexed Disodium 培美曲塞二钠 | 137281-23-3 | Class A | Y20190009842 |
| Pemetrexed Disodium 培美曲塞二钠 | 137281-23-3 | Class A | Y20180001578 |
| Raltitrexed 雷替曲塞 | 112887-68-0 | Class I | Y20240001047 |
| Regorafenib 瑞戈非尼 | 755037-03-7 | Class A | Y20220001298 |
| Ruxolitinib 磷酸芦可替尼 | 941678-49-5 | Class I | Y20250000835 |
| Sodium Nitrite 亚硝酸钠 | 7632-00-0 | Class A | Y20220000687 |
| Sodium Thiosulfate 硫代硫酸钠 | - | Class A | Y20200000782 |
| Sorafenib 甲苯磺酸索拉非尼 | 284461-73-0 | Class A | Y20170001702 |
| Tenofovir Alafenamide 富马酸丙酚替诺福韦 | 379270-37-8 | Class A | Y20200001418 |
| Tenofovir Disoproxil 酒石酸替诺福韦二吡呋酯 | 201341-05-1 | Class A | Y20190006645 |
| Venlafaxine 文拉法辛 | - | Class A | Y20190007011 |
🇺🇸 DMF 注册 (24)
🇪🇺 CEP 注册 (12)
| Product | CAS | CEP Number | Date |
|---|---|---|---|
| Clindamycin Hydrochloride 盐酸克林霉素（供口服用） | 18323-44-9 | R1-CEP 2000-210 - Rev 08 | - |
| Clindamycin Hydrochloride, Process C | 21462-39-5 | CEP 2024-484 - Rev 00 | - |
| Clindamycin Phosphate 磷酸克林霉素 | 24729-96-2 | R1-CEP 2005-033 - Rev 03 | - |
| Clindamycin Phosphate, Alternative Process | 24729-96-2 | R1-CEP 2009-398 - Rev 04 | - |
| Glimepiride, Micropowder And Super Micropowder 格列美脲 | 93479-97-1 | R1-CEP 2007-035 - Rev 00 | - |
| Granisetron Hydrochloride 盐酸格拉司琼 | 107007-99-8 | R1-CEP 2007-247 - Rev 02 | - |
| Mitoxantrone Hydrochloride 盐酸米托蒽醌 | 70476-82-3 | R1-CEP 2001-143 - Rev 05 | - |
| Pemetrexed Disodium 2.5-hydrate | 357166-30-4 | R0-CEP 2021-406 - Rev 00 | - |
| Sodium Alendronate Trihydrate 阿仑膦酸 钠 三水合物 | 121268-17-5 | R0-CEP 2009-288 - Rev 01 | - |
| Sorafenib Tosilate | 475207-59-1 | CEP 2023-373 - Rev 00 | - |
| Venlafaxine Hydrochloride, Form B | 99300-78-4 | R1-CEP 2009-029 - Rev 01 | - |
| Venlafaxine Hydrochloride, Form C | 99300-78-4 | R1-CEP 2009-062 - Rev 01 | - |
Source: cde+fda_direct; DMF高置信 | Updated: 2026-04-09 07:23:01